|
If you look around the board at the various signatures, you will see both regimens listed. Like the abstracts show, the statistical significance between the two is minimal (if any real difference). We went with TCH because Jill wanted to minimize her heart risk.
__________________
Husband to Jill
Diagnosed 10/05, age 39
R Mast 11/05
Stage II N0
Her2+ er/pr+
Revision Mast due to positive margins 12/05
TCH Chemo started 1/06
Finished TC 4/06
Tamoxifen
Finished H 12/29/06
Currently NED
|